| name | Hormonal Contraception (various formulations) |
| classification | Combined hormonal contraceptives (CHCs), Progestin-only pills (POPs), injectable contraceptives, transdermal patches, vaginal rings, and intrauterine devices (IUDs). Specific formulations vary based on the active hormones (estrogen and progestin types) and delivery method. |
| pharmacokinetics | Pharmacokinetic profiles vary significantly depending on the specific hormonal contraceptive. Generally, hormones are absorbed from the site of administration (e.g., oral, transdermal, vaginal) and circulate in the bloodstream, suppressing ovulation and altering cervical mucus. Metabolism and excretion routes differ based on the specific formulation. Consult the specific product information for detailed pharmacokinetic data. |
| suggested dosage | Dosage varies significantly by the formulation and individual needs. Patients should always follow the instructions provided with their prescribed hormonal contraceptive. A doctor will determine the appropriate dosage and formulation. |
| indications | | 1 | Prevention of pregnancy. | | 2 | Management of menstrual irregularities (e.g., heavy bleeding, painful periods). | | 3 | Treatment of acne, hirsutism, and other conditions related to hormonal imbalances. |
|
| safety in pregnancy | Absolutely contraindicated. Hormonal contraceptives are designed to prevent pregnancy. If a woman is pregnant or suspects she may be pregnant, she should immediately stop use and seek medical attention. |
| safety in breastfeeding | Some formulations are safe for breastfeeding mothers. Others may affect milk production or have unknown effects. A doctor should advise on the most appropriate formulation to use while breastfeeding. |
| side effects | | 1 | Nausea, vomiting, breast tenderness, headaches, mood changes, weight fluctuations, bleeding irregularities (spotting or breakthrough bleeding). | | 2 | Increased risk of blood clots (thrombosis), stroke, heart attack (risk factors need to be assessed). | | 3 | Rarely, severe allergic reactions, liver problems, and gallbladder disease. |
|
| alternatives | |
| contraindications | | 1 | History of blood clots (thrombosis), stroke, or heart attack. | | 2 | Severe liver disease. | | 3 | Certain types of cancers (breast, uterine). | | 4 | Migraines with aura. | | 5 | Uncontrolled hypertension. | | 6 | Known hypersensitivity to any components of the contraceptive. |
|
| interactions | Certain medications, including antibiotics and some herbal remedies, may affect the effectiveness of hormonal contraceptives. Patients should inform their doctors about all medications and supplements they are taking. |
| warnings and precautions | | 1 | Regular checkups are important to monitor for any potential adverse effects. | | 2 | Patients should be informed about potential risks and benefits and discuss any concerns with their doctor. | | 3 | Risk factors for cardiovascular issues must be considered (smoking, high blood pressure, family history). | | 4 | Proper use of the chosen method is crucial for effectiveness. |
|
| additional informations | A detailed medical history, including family history, lifestyle, and current health status, is necessary for evaluating suitability. Patient should discuss potential risks and benefits with a healthcare professional before starting hormonal contraception. |
| patient information | | age | 25 years | | weight | 70 kg | | medical suitability | Cannot be determined from the information provided. A consultation with a medical doctor is essential for assessing medical suitability. |
|
